Bellerophon Therapeutics, Inc. (BLPH)
OTCMKTS: BLPH · Delayed Price · USD
0.0510
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
Bellerophon Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for BLPH.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for BLPH.
Recommendation Trends
| Rating | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $2 | Strong Buy | Maintains | $30 → $2 | +3,821.57% | Jun 6, 2023 |
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 6, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +58,723.53% | May 17, 2023 |
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +68,527.45% | May 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +58,723.53% | Apr 4, 2023 |
Financial Forecast
Revenue This Year
5.75M
Revenue Next Year
n/a
from 5.75M
EPS This Year
-1.02
from -2.08
EPS Next Year
-1.86
from -1.02
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 5.9M | n/a | 137.6M |
| Avg | 5.8M | n/a | 133.7M |
| Low | 5.5M | n/a | 128.4M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -1.05 | -1.91 | 1.54 |
| Avg | -1.02 | -1.86 | 1.50 |
| Low | -0.98 | -1.78 | 1.44 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.